Inhibitor Therapeutics, Inc. Gain (Loss) on Sales of Loans, Net
Inhibitor Therapeutics, Inc. (INTI) reported Gain (Loss) on Sales of Loans, Net of $0 for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnSalesOfLoansNet · last filed 2023-03-31
- Inhibitor Therapeutics, Inc. gain (loss) on sales of loans, net for the quarter ending 2022-09-30 was $0.00.
- Inhibitor Therapeutics, Inc. gain (loss) on sales of loans, net for the quarter ending 2022-06-30 was $0.00.
- Inhibitor Therapeutics, Inc. gain (loss) on sales of loans, net for the quarter ending 2022-03-31 was $0.00, a 100.00% decline year-over-year.
- Inhibitor Therapeutics, Inc. gain (loss) on sales of loans, net for the quarter ending 2021-12-31 was $0.00.
- Inhibitor Therapeutics, Inc. gain (loss) on sales of loans, net for fiscal 2021 was $41.60K.
- Inhibitor Therapeutics, Inc. gain (loss) on sales of loans, net for fiscal 2020 was $0.00.
| Period end | Gain (Loss) on Sales of Loans, Net 3 month | Gain (Loss) on Sales of Loans, Net 6 month | Gain (Loss) on Sales of Loans, Net 9 month | Gain (Loss) on Sales of Loans, Net 12 month |
|---|---|---|---|---|
| 2022-09-30 | $0.00 10-Q · filed 2022-11-14 | $0.00 derived: sum of 2 quarters · filed 2022-11-14 | $0.00 10-Q · filed 2022-11-14 | $0.00 derived: sum of 4 quarters · filed 2023-03-31 |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-12 | $0.00 10-Q · filed 2022-08-12 | $0.00 derived: sum of 3 quarters · filed 2023-03-31 | $0.00 derived: sum of 4 quarters · filed 2023-03-31 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-13 | $0.00 derived: sum of 2 quarters · filed 2023-03-31 | $0.00 derived: sum of 3 quarters · filed 2023-03-31 | $0.00 derived: sum of 4 quarters · filed 2023-03-31 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $0.00 derived: sum of 2 quarters · filed 2023-03-31 | $0.00 derived: sum of 3 quarters · filed 2023-03-31 | $41.60K 10-K · filed 2023-03-31 |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-14 | $0.00 derived: sum of 2 quarters · filed 2022-11-14 | $41.60K 10-Q · filed 2022-11-14 | $41.60K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $0.00 10-Q · filed 2022-08-12 | $41.60K 10-Q · filed 2022-08-12 | $41.60K derived: sum of 3 quarters · filed 2022-08-12 | $41.60K derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | $41.60K 10-Q · filed 2022-05-13 | $41.60K derived: sum of 2 quarters · filed 2022-05-13 | $41.60K derived: sum of 3 quarters · filed 2022-05-13 | $41.60K derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $0.00 derived: sum of 2 quarters · filed 2022-03-30 | $0.00 derived: sum of 3 quarters · filed 2022-03-30 | $0.00 10-K · filed 2022-03-30 |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-12 | $0.00 derived: sum of 2 quarters · filed 2021-11-12 | $0.00 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $0.00 10-Q · filed 2021-08-13 | $0.00 10-Q · filed 2021-08-13 | ||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-14 |